Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoimmunotherapy for Patients With Potentially Platinum Sensitive Müllerian Carcinomas
NCT00501644Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2003
- Primary completion
- Jan 2009
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b, sargramostim in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2003; status: completed.
02
Drugs
interferon gamma-1bsargramostim
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00501644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501644.